These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 5079227)
1. Relationship between desipramine plasma levels and the effect in Parkinson's syndrome. Muscettola GB; Giovannucci M; Montanini R; Morselli PL; Garattini S Rev Eur Etud Clin Biol; 1972 Apr; 17(4):375-9. PubMed ID: 5079227 [No Abstract] [Full Text] [Related]
2. [Desipramine in the therapy of Parkinson's disease]. De Divitiis E; Signorelli CD; Cerillo A Rass Int Clin Ter; 1971 Feb; 51(4):222-6. PubMed ID: 5576944 [No Abstract] [Full Text] [Related]
3. [Neurological aspects and modern trends in therapy of Parkinson's disease]. Pavoncello S; Di Bianco V; Di Castro A; Caviglia A; Cellitti M Clin Ter; 1980 Feb; 92(4):433-8. PubMed ID: 7449321 [No Abstract] [Full Text] [Related]
4. Parkinson's disease. Taylor J Aust Nurses J; 1977 Nov; 7(5):27. PubMed ID: 245293 [No Abstract] [Full Text] [Related]
5. Orobuccal dyskinesia associated with trihexyphenidyl therapy in a patient with Parkinson's disease. Hauser RA; Olanow CW Mov Disord; 1993 Oct; 8(4):512-4. PubMed ID: 8232363 [TBL] [Abstract][Full Text] [Related]
6. [Effect of a combined L-Dopa and decarboxylase inhibitor (Ro 4-4602) therapy in parkinsonism patients. Quantitative analysis of bradykinesia using reaction times]. Kaufmann W; Butz P; Wiesendanger M Dtsch Z Nervenheilkd; 1969 Dec; 197(1):85-100. PubMed ID: 5364658 [No Abstract] [Full Text] [Related]
7. Desipramine in treatment of Parkinson's disease. A placebo-controlled study. Laitinen L Acta Neurol Scand; 1969; 45(1):109-13. PubMed ID: 4896078 [No Abstract] [Full Text] [Related]
8. [Treatment of parkinsonism]. Parkenberg H Ugeskr Laeger; 1976 Apr; 138(18):1104-5. PubMed ID: 1265907 [No Abstract] [Full Text] [Related]
9. [Attempt at treating parkinsonism with L-dopa and Artane]. Stelmasiak Z; Lackowska H; Maksymowicz B Pol Tyg Lek; 1971 Aug; 26(34):1325-6. PubMed ID: 5110789 [No Abstract] [Full Text] [Related]
10. Lack of indication for use of antiparkinson medication. A follow-up study. Pecknold JC; Ananth JV; Ban TA; Lehmann HE Dis Nerv Syst; 1971 Aug; 32(8):538-41. PubMed ID: 5094160 [No Abstract] [Full Text] [Related]
11. [Disturbance of micturition in Parkinson's disease]. Sakakibara R; Uchiyama T; Yoshiyama M; Hattori T No To Shinkei; 2001 Nov; 53(11):1009-14. PubMed ID: 11761908 [No Abstract] [Full Text] [Related]
13. [Kr 339, a new tremor-inhibiting preparation for the therapy of Parkinson's syndrome]. Avenarius HJ; Gerstenbrand F Wien Klin Wochenschr; 1968 Jun; 80(23):460-2. PubMed ID: 5704572 [No Abstract] [Full Text] [Related]
14. [Tactile hallucinations induced by trihexyphenidyl in a patient with Parkinson's disease]. Funakawa I; Jinnai K Rinsho Shinkeigaku; 2005 Feb; 45(2):125-7. PubMed ID: 15782612 [TBL] [Abstract][Full Text] [Related]
15. [Personal experience in the treatment of Parkinson's disease with L-Dopa]. Figuerido JA; De la HerrĂ¡n J Rev Clin Esp; 1970 Dec; 119(6):555-62. PubMed ID: 5509794 [No Abstract] [Full Text] [Related]
16. Drug management of Parkinson's disease. Kishore A; Snow BJ Can Fam Physician; 1996 May; 42():946-52. PubMed ID: 8688697 [TBL] [Abstract][Full Text] [Related]
17. Multiple medication use presenting as Parkinson's dementia complex: a message from Titanic. Preskorn SH J Psychiatr Pract; 2008 Jan; 14(1):45-54. PubMed ID: 18212602 [No Abstract] [Full Text] [Related]